Results 1 to 10 of about 471,639 (303)

Subunit vaccines for Acinetobacter baumannii

open access: yesFrontiers in Immunology, 2023
Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen in hospitals. A. baumannii infection has become a challenging problem in clinical practice due to the increasing number of multidrug-resistant strains and their ...
Ning Yang   +6 more
doaj   +3 more sources

Advances in protein subunit vaccines against tuberculosis [PDF]

open access: yesFrontiers in Immunology, 2023
Tuberculosis (TB), also known as the “White Plague”, is caused by Mycobacterium tuberculosis (Mtb). Before the COVID-19 epidemic, TB had the highest mortality rate of any single infectious disease.
Ying Zhang   +5 more
doaj   +2 more sources

Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis

open access: yesVaccines, 2021
The only licensed vaccine against tuberculosis is BCG. However, BCG has failed to provide consistent protection against tuberculosis, especially pulmonary disease in adults.
Abu Salim Mustafa
doaj   +2 more sources

Carbohydrate Immune Adjuvants in Subunit Vaccines [PDF]

open access: yesPharmaceutics, 2020
Modern subunit vaccines are composed of antigens and a delivery system and/or adjuvant (immune stimulator) that triggers the desired immune responses.
Sahra Bashiri   +3 more
doaj   +6 more sources

Preparation and immunological effects of a bivalent subunit candidate vaccine based on the PCV-Cap-2-3 gene engineered from baculovirus [PDF]

open access: yesFrontiers in Veterinary Science
IntroductionPorcine circoviruses (PCVs), belonging to the genus Circovirus in the family Circoviridae, are prevalent worldwide and pose a serious threat to the pig industry.
Yi Liu   +11 more
doaj   +2 more sources

Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies

open access: yesActa Pharmaceutica Sinica B, 2023
Designing and manufacturing safe and effective vaccines is a crucial challenge for human health worldwide. Research on adjuvant-based subunit vaccines is increasingly being explored to meet clinical needs.
Yingying Hou   +5 more
doaj   +1 more source

Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development

open access: yesEBioMedicine, 2020
Background: Coronaviruses pose a serious threat to global health as evidenced by Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and COVID-19.
Eun Kim   +12 more
doaj   +1 more source

A Sneak Peek into COVID-19 Vaccines-Present Status [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
The Coronavirus Disease 2019 (COVID-19) pandemic has taken a toll on all of us for one year with more than 1.94 million deaths. Despite many educational interventions and precautionary measures, there is increasing number of cases with rising mortality.
SWATHI GURAJALA
doaj   +1 more source

Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome Vaccines

open access: yesVeterinary Sciences, 2023
Porcine reproductive and respiratory syndrome (PRRS) is a highly contagious disease in the pig industry, but its pathogenesis is not yet fully understood.
Hang Zhang   +8 more
doaj   +1 more source

Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex

open access: yesmSphere, 2018
The native Invaplex (InvaplexNAT) vaccine and adjuvant is an ion exchange-purified product derived from the water extract of virulent Shigella species.
K. Ross Turbyfill   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy